Private health insurers want to fund more out-of-hospital care. Here’s why that’s such a problem.
Articles on Health insurance
Displaying 1 - 20 of 151 articles
Those signs about surprise insurance charges are intended to keep patients informed – but new research points to a negative side effect.
Here’s what you need to know about the different types of cover. And if your claim is rejected, what to do next.
Medicaid improves access to care for low-wage workers who cannot survive on bare-bone benefits offered by their employers.
The justices ruled that a key preventive health task force has authority because it is appointed by the Health and Human Services secretary. Some experts worry that RFK Jr. could politicize it.
Health insurance companies use AI to decide which health care treatment to cover. State laws and federal agencies are now moving toward regulating these algorithms.
When that important link is broken, your health gets worse and the costs borne by the whole health care system for your treatment rise.
All told, more than 16 million Americans could become uninsured, reversing major progress seen since the Affordable Care Act’s passage in 2010.
Research shows that decades of policy choices shaped today’s fragmented health care system – which is precisely why reform is so difficult.
A damaged home and the psychological stress that comes with living through a major cyclone can prompt people to buy private health insurance.
After a group of employers refused to provide their employees access to free HIV prevention treatment, the Supreme Court may decide whether insurers are required to fully cover preventive care.
At a time when California’s farm operators are struggling to hire enough people, providing better benefits could attract more workers who are citizens or have legal immigration status.
Medicare Advantage − the private option that costs taxpayers extra and requires prior approval − is the default for some state agencies and corporations.
Health Secretary Robert F. Kennedy Jr.’s new vision for US health policy prioritizes deregulation and leaves Americans with fewer benefits, services and protections.
A number of things could affect the success of Nigeria’s scheme to provide free caesarian sections.
Overseeing the FDA, NIH and several other public health and medical research divisions, the HHS secretary is a powerful force in how the nation accesses health care.
It’s time to move from rage to regulation, an insurance expert argues.
As the middlemen between drug companies and insurers, PBMs are shoo-ins as the villains behind high drug prices. But they do play a useful role in the health marketplace.
At a moment of soul-searching about health care in the US, an expert on global health puts the American system in perspective.
The murder of a health care insurance executive has brought scrutiny to the ways that insurance companies can make it difficult for insured patients to get the care they need.
Top contributors
-
Associate Professor of Public Health, The Ohio State University
-
Associate Professor of Health Law, Policy and Management, Boston University
-
Professor of Health Finance, Weatherhead School of Management & School of Medicine, Case Western Reserve University
-
Assistant Professor of Social, Behavioral and Population Sciences, Tulane University
-
Professor of Health Economics, The University of Melbourne
-
Professor of Health Law and Bioethics, Case Western Reserve University
-
Research Scientist and Director of Research Training in Health Policy and Economics, University of Southern California
-
Research scientist of Health Policy and Economics, University of Southern California
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Professor, Department of Health Policy, London School of Economics and Political Science
-
Dean of the Sol Price School of Public Policy; Distinguished Professor of Pharmacy, Public Policy, and Economics, University of Southern California
-
Senior Lecturer, University of Sydney
-
Associate Professor of Health Policy, Management and Behavior, University at Albany, State University of New York
-
Quintiles Professor of Pharmaceutical Development and Regulatory Innovation, Schaeffer Center for Health Policy and Economics, University of Southern California
-
Professor of Gerontology, UMass Boston
